Ginsenoside Rb1 prevents MPTP-induced changes in hippocampal memory via regulation of the α-synuclein/PSD-95 pathway.
In this study, we found that Rb1 can prevent the spatial learning and memory deficits, increase long-term potentiation (LTP) and hippocampal glutamatergic transmission in the MPTP mouse model. The underlying neuroprotective mechanism of Rb1-improved synaptic plasticity involves Rb1 promoting hippocampal CA3 α-synuclein expression, restoring the glutamate in the CA3-schaffer collateral-CA1 pathway, and sequentially increasing postsynaptic density-95 (PSD-95) expression. Thus, we provide evidence that Rb1 modulates memory function, synaptic plasticity, and excitatory transmission via the trans-synaptic α-synuclein/PSD-95 pathway. Our findings suggest that Rb1 may serve as a functional drug in treating the memory deficiency in PD.
PMID: 30958793 [PubMed - as supplied by publisher]
Source: Aging - Category: Biomedical Science Authors: Qu S, Meng X, Liu Y, Zhang X, Zhang Y Tags: Aging (Albany NY) Source Type: research
More News: Biomedical Science | Brain | Learning | Men | Neurology | Parkinson's Disease | Study | Toxicology | Universities & Medical Training